Market Tracker

10/17 5:16pm ET

Rexahn Pharmaceuticals Inc (NYSE American:RNN)

2.01
Delayed Data
As of Oct 17
 -0.03 / -1.47%
Today’s Change
1.27
Today|||52-Week Range
7.10
+41.65%
Year-to-Date

Today’s Trading

Previous close2.04
Today’s open2.01
Day’s range1.99 - 2.04
Volume599,005
Average volume (3 months)297,490
Market cap$58.1M
Dividend yield--
Data as of 7:59pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-222.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.84

Competitors

 Today’s
change
Today’s
% change
SPHSSophiris Bio Inc-0.01-0.44%
EIGREiger BioPharmaceuti...-0.35-2.95%
NOVNNovan Inc+0.02+0.40%
NBYNovaBay Pharmaceutic...-0.05-1.14%
Data as of 3:59pm ET, 10/17/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$9.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts